MATINAS BIOPHARMA HOLDINGS I (MTNB)
US5768101058 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -22.94M | -21.00M | -23.28M | -22.45M | -17.37M | |||
| Depreciation Amortization | 393.00K | 356.00K | 280.13K | 290.02K | 328.76K | |||
| Change In Working Capital | 1.67M | -4.79M | 1.53M | -508.69K | -492.07K | |||
| Other non cash items | 5.60M | 6.27M | 6.25M | 5.30M | 3.44M | |||
| OPERATING CASH FLOW | -15.28M | -19.16M | -15.22M | -17.37M | -14.09M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -218.00K | -892.00K | -260.38K | -5.75K | -405.60K | |||
| Other Investing Activity | 13.46M | 5.77M | 17.03M | -40.66M | -5.61M | |||
| INVESTING CASH FLOW | 13.24M | 4.88M | 16.77M | -40.67M | -6.01M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -7.00K | -20.00K | -30.85K | -54.67K | -281.56K | |||
| Stock Issued/Repurchased | 0.00 | 99.00K | 7.00M | 48.10M | 30.13M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | 0.00 | |||
| FINANCING CASH FLOW | -7.00K | 79.00K | 6.96M | 48.05M | 29.85M | |||
| CHANGE IN CASH | -2.04M | -14.20M | 8.51M | -9.99M | 9.75M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -15.28M | -19.16M | -15.22M | -17.37M | -14.09M | |||
| Capital Expenditure | -218.00K | -892.00K | -260.38K | -5.75K | -405.60K | |||
| FREE CASH FLOW | -15.50M | -20.05M | -15.48M | -17.37M | -14.50M | |||
All data in USD